TY - JOUR
T1 - Prognostic value of tricuspid regurgitation
AU - Leone, Pier Pasquale
AU - Chiarito, Mauro
AU - Regazzoli, Damiano
AU - Pellegrino, Marta
AU - Monti, Lorenzo
AU - Pagliaro, Beniamino
AU - Loiacono, Ferdinando
AU - Stefanini, Giulio
AU - Pini, Daniela
AU - Reimers, Bernhard
AU - Colombo, Antonio
AU - Latib, Azeem
AU - Mangieri, Antonio
N1 - Publisher Copyright:
© 2022 IMR Press Limited. All rights reserved.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Tricuspid regurgitation (TR) has a considerable prevalence in the overall population, that further increases in selected categories of patients. Three morphologic types of TR prevail, namely primary, secondary and atrial TR, mostly, but not always, occurring in different subsets of patients. Recent evidences demonstrate a negative impact of TR on outcomes, irrespective of etiology and even when less than severe in grading. Unfortunately, current surgical standards are void of strong prospective evidence of positive impact on clinical outcomes. While on one hand recent advances in diagnosis and risk stratification of patients with TR are shedding light onto the population that may benefit from intervention and its appropriate timing, on the other hand the arrival on stage of percutaneous treatment options is widening even more the therapeutic options for such population. In this review we will address and discuss the available evidence on the prognostic impact of TR in different clinical contexts encountered in practice.
AB - Tricuspid regurgitation (TR) has a considerable prevalence in the overall population, that further increases in selected categories of patients. Three morphologic types of TR prevail, namely primary, secondary and atrial TR, mostly, but not always, occurring in different subsets of patients. Recent evidences demonstrate a negative impact of TR on outcomes, irrespective of etiology and even when less than severe in grading. Unfortunately, current surgical standards are void of strong prospective evidence of positive impact on clinical outcomes. While on one hand recent advances in diagnosis and risk stratification of patients with TR are shedding light onto the population that may benefit from intervention and its appropriate timing, on the other hand the arrival on stage of percutaneous treatment options is widening even more the therapeutic options for such population. In this review we will address and discuss the available evidence on the prognostic impact of TR in different clinical contexts encountered in practice.
KW - heart failure
KW - right ventricle
KW - tricuspid regurgitation
KW - valvular heart disease
UR - http://www.scopus.com/inward/record.url?scp=85125593428&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125593428&partnerID=8YFLogxK
U2 - 10.31083/j.rcm2302076
DO - 10.31083/j.rcm2302076
M3 - Review article
C2 - 35229567
AN - SCOPUS:85125593428
SN - 1530-6550
VL - 23
JO - Reviews in Cardiovascular Medicine
JF - Reviews in Cardiovascular Medicine
IS - 2
M1 - 076
ER -